(R)-(-)-1-Methyl-3-pyrrolidinol

• Catalog No.: 647241
• CAS Number: 104641-60-3
• M. F.: C5H11NO
• M. W.: 101.14694
• Purity: 97%

SYNONYMS

• Title: (R)-(-)-1-甲基-3-吡咯烷醇
• IUPAC name: (3R)-1-methylpyrrolidin-3-ol
• IUPAC Traditional name: (3R)-1-methylpyrrolidin-3-ol
• Synonyms: (R)-(-)-3-Hydroxy-N-methylpyrrolidine; (3R)-1-Methylpyrrolidin-3-ol; (R)-N-Methyl-3-pyrrolidinol; (R)-(-)-3-羟基-N-甲基吡咯烷

DATABASE IDS

• CAS Number: 104641-60-3
• PubChem SID: 24883519
• MDL Number: MFCD03788747

PROPERTIES

• Empirical Formula (Hill Notation): C5H11NO
• Purity: 97%
• Boiling Point: 50-52 °C/1 mmHg(lit.)
• Density: 0.921 g/mL at 25 °C(lit.)
• Flash Point: 70 °C
• Flash Point: 158 °F
• Optical Rotation: [α]20/D -7°, c = 1% in chloroform
• Refractive Index: n20/D 1.4640(lit.)
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: Eyeshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• German water hazard class: 3

DETAILS

Description (English)

Packaging
1, 5 g in glass bottle
Application
Reactant for:
• Asymmetric synthesis of constrained (-)-S-adenosyl-L-homocysteine (SAH) analogs as DNA methyltransferase inhibitors1
• Preparation of diaryl acylaminopyrimidines as adenosine A2A antagonists2
• Synthesis of analogs of istaroxime, a potent inhibitor of Na+,K+-ATPase3
• Synthesis of pharmacologically active stereoisomers of N-substituted soft anticholinergics4

Description (简体中文)

包装
1, 5 g in glass bottle
Application
Reactant for:
• Asymmetric synthesis of constrained (-)-S-adenosyl-L-homocysteine (SAH) analogs as DNA methyltransferase inhibitors1
• Preparation of diaryl acylaminopyrimidines as adenosine A2A antagonists2
• Synthesis of analogs of istaroxime, a potent inhibitor of Na+,K+-ATPase3
• Synthesis of pharmacologically active stereoisomers of N-substituted soft anticholinergics4